Tap into one of the world’s fastest-growing medical device markets with strategic regulatory support.


The Asia medical device market is one of the fastest-growing regions worldwide, driven by innovation and increased demand for healthcare solutions.
However, regulatory frameworks across Asia–Pacific and the Middle East are highly diverse, with each authority setting its own standards for product registration, documentation, and local representation.
At Sobel, we help manufacturers navigate these complex pathways with confidence in every target country!
medical device and IVD companies outside Asia seeking market access in United Arab Emirates, Dubai, Japan, South Korea or ASEAN countries.
companies based in Asia or the Middle East that require regulatory assistance to register and commercialize imported devices.
global manufacturers already selling internationally who need local representation and compliance alignment in Asian markets.
companies that need continuous support with renewals according to PMDA, MFDS, or UAE requirements.
innovators developing wearable or digital medical devices planning to enter the Asia–Pacific healthcare market.
manufacturers providing materials or components for medical devices who must comply with Asia-Pacific packaging and labeling standards.

Our consultants understand the unique regulatory requirements of Japan (PMDA), South Korea (MFDS), ASEAN members under the AMDD, and the United Arab Emirates.
From classification and documentation to submission, we help your company managing the entire registration process for your devices.
Ensure compliance with representation requirements through Sobel’s network of trusted partners in Asia and the Middle East.
We connect your Asia–Pacific operations to your global compliance framework, bridging regional regulations with MDR, FDA, and ANVISA requirements.
Gain insights into the Asia–Pacific wearable medical device market and emerging sectors such as packaging and software-based devices.
Caso a Anvisa solicite esclarecimentos, estamos prontos para responder.
We would love to speak with you.
Feel free to reach out using the below details.
We provide regulatory services for Japan (PMDA), South Korea (MFDS), ASEAN countries under the AMDD framework, and the United Arab Emirates (including Dubai and Abu Dhabi).
Yes. Through our network of authorized partners, we offer local representation services where required by national regulations.
Our consulting covers all device classes — from low-risk consumables to complex diagnostic and implantable devices — including software-driven and wearable products.
Timelines vary by market. For example, Japan and South Korea may require additional clinical documentation, while Dubai’s process is often faster for products already approved by recognized authorities. At Sobel, you’ll have access to a clear regulatory timeline and can monitor every stage of your submission in real time.
Partnering with Sobel means optimizing time, resources, and compliance. Our consultants understand the differences between Asian regulatory systems and global frameworks, helping you avoid unnecessary rework, anticipate documentation needs, and streamline your approval process. With a strategic and transparent approach, we ensure your submissions meet every market’s specific requirements — efficiently and cost-effectively.
In many cases, yes. Technical documentation such as test reports, certificates, and clinical data can often be leveraged, depending on each authority’s acceptance criteria. Sobel’s experts evaluate your existing documents, identify what can be adapted or translated, and guide you through any additional requirements needed for full compliance in Asian and Middle Eastern markets.